Last Updated on 4 months by News Admin
President Donald Trump is now being treated with dexamethasone, a common steroid that has demonstrated in clinical trials in the U.K. that it can reduce mortality in severely ill COVID-19 patients.
Dexamethasone, a type of corticosteroid, has been considered a treatment only for severely ill COVID-19 patients; “corticosteroids also appear to be associated with benefit among critically ill patients with COVID-19 whether they are receiving mechanical ventilation or oxygen without mechanical ventilation,” researchers wrote in September in a JAMA editorial.
One of Trump’s physicians said Sunday morning during a press conference that Trump received the first dose of dexamethasone on Saturday.
